NDC 55289-920-90
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-90
- Package NDCs from labels
- 55289-920-90
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin | MOXIFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 1c6f7150-a8f4-408f-956f-c26d37030cf4 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 3f96aeb1-a533-4d36-9a1f-62fc094b6754 | 2025-10-08 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Fluvoxamine Maleate | FLUVOXAMINE MALEATE | PD-Rx Pharmaceuticals, Inc. | 9972efbb-46cd-45b7-b71c-35032311b70c | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 89d367b1-de04-4970-9967-27a1c7711c0f | 2025-10-01 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Clonazepam | CLONAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08d0a109-3307-47b5-8ff2-c0ad83e66f08 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Clonazepam | CLONAZEPAM | PD-Rx Pharmaceuticals, Inc. | 9a74ea97-1c00-4d96-a06f-81c183943dc6 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Clonazepam | CLONAZEPAM | PD-Rx Pharmaceuticals, Inc. | ca79f244-7e6e-4612-af26-e6e5cefbd3a2 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 270398a0-21b8-407b-af76-4aeef90f72be | 2025-10-01 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2025-10-01 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | AvPAK | 3fa14fa4-45a7-6ef4-e063-6394a90a1dcd | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | dcb39c6b-430d-4b3d-ba6f-5bf1efe116aa | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFOLXACIN | PD-Rx Pharmaceuticals, Inc. | 3b3c0874-90b7-deda-e063-6394a90a7802 | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2025-09-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Gemfibrozil | GEMFIBROZIL | PD-Rx Pharmaceuticals, Inc. | 5501438d-5247-4f2a-8e15-085276d01725 | 2025-09-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Levocetirizine Dihydrochloride | LEVOCETIRIZINE DIHYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 344ba2d6-4e17-4cef-bd7b-248fbb1af3b6 | 2025-09-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | 9558d296-8edd-4aa1-875a-6247f9a8374d | 2025-09-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol succinate | METOPROLOL SUCCINATE | PD-Rx Pharmaceuticals, Inc. | 189b6a89-8de8-4a62-a54b-a6c52be870ca | 2025-09-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.